Intellectual Property (IP)
Pharma companies attempt to overturn Brazilian Supreme Court’s historic decision on patents
Felipe Carvalho Borges da Fonseca
Susana Rodrigues Cavalcanti Van Der Ploeg
Maria Clara Pfeiffer Noronha
Alan Rossi Silva
/
December 15, 2022
Pharmaceutical companies are trying to undermine a decision of the Brazilian Supreme Court from 2021 which puts health ahead of private profit
The Pandemic Age and the debates around intellectual property
Thiru Balasubramaniam of Knowledge Ecology International talks about debates on intellectual property in the context of the COVID-19 pandemic and the role of the World Intellectual Property Organization
Private monopolies hinder progress on public health: intellectual property at the 75th World Health Assembly
Obstruction by pharmaceutical companies from the Global North and misuse of monopoly privileges continue to slow down research into new vaccines and medicines, with disastrous effects for people’s health in the Global South. Discussions at the 75th World Health Assembly did little to address this
- Brazil approves end to 6×1 work schedule and reduction of the work week to 40 hours
- Israel kills 31 people in Lebanon on the eve of Eid al-Adha
- Israel carries out sixth consecutive Eid massacre in Gaza
- Far-right Janez Janša to return for fourth government term in Slovenia
- With peace deal nearly final, US launches fresh attacks on Iran
